Skip to main content
Log in

Comparison of early and delayed anticoagulation therapy after ischemic stroke in patients with atrial fibrillation: a systematic review and meta-analysis

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

The optimal initiation timing of oral anticoagulants (OACs) remains controversial in patients with atrial fibrillation (AF)-related acute ischemic stroke (AIS). The aim of this study is to compare the efficacy and safety of early OACs initiation with that of the delayed initiation for AIS and AF.We searched systematically the following mainstream databases: PubMed, Embase, and Web of Science from the inception to July 2023 for studies that compared the early initiation with the delayed initiation of OACs for AF-related AIS patients. Outcome measures were the incidence of hemorrhagic events, ischemic events, and combined outcomes, as well as all-cause mortality.There were 12 eligible articles included (10 cohort studies and 2 RCT), involving 11421 patients (5690 patients in the early-initiation group and 5731 in the delayed-initiation group). Meta-analysis revealed that patients receiving OACs at the early stage of stroke had a lower incidence of ischemic events (OR: 0.68; 95% CI: 0.55,0.84; p = 0.0003) and combined outcomes (OR=0.74, 95% CI (0.57,0.95), p=0.02). No significant differences were identified in the incidence of hemorrhagic events (p = 0.26) and all-cause mortality ( p = 0.20) between the groups.Early initiation of anticoagulation therapy would be preferable in lowering the incidence of ischemic events and combined outcomes in AIS patients with AF. It is safe compared to the delayed-initiation strategy. However, the conclusion of this study needs to be further validated by more well-designed RCTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Group SRiAFW (2007) Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 69(6):546–554. https://doi.org/10.1212/01.wnl.0000267275.68538.8d

    Article  Google Scholar 

  2. Hart RG, Coull BM, Hart D (1983) Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 14(5):688–693. https://doi.org/10.1161/01.str.14.5.688

    Article  CAS  PubMed  Google Scholar 

  3. Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST et al (2019) Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol 18(1):117–126. https://doi.org/10.1016/s1474-4422(18)30356-9

    Article  PubMed  Google Scholar 

  4. Mizoguchi T, Tanaka K, Toyoda K, Yoshimura S, Itabashi R, Takagi M, Todo K et al (2020) Early initiation of direct oral Anticoagulants after Onset of Stroke and short- and long-term outcomes of patients with Nonvalvular Atrial Fibrillation. Stroke 51(3):883–891. https://doi.org/10.1161/strokeaha.119.028118

    Article  PubMed  Google Scholar 

  5. Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, Paciaroni M et al (2023) Early versus later anticoagulation for stroke with Atrial Fibrillation. N Engl J Med 388(26):2411–2421. https://doi.org/10.1056/NEJMoa2303048

    Article  CAS  PubMed  Google Scholar 

  6. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V et al (2008) Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39(8):2249–2256. https://doi.org/10.1161/strokeaha.107.510321

    Article  PubMed  Google Scholar 

  7. Al Bakr AI, AlOmar RS, Nada MAF, Ishaque N, Aljaafari D, Hadhiah K, Al Khmais FA et al (2020) Timing to start anticoagulants after acute ischemic stroke with non-valvular atrial fibrillation. J Neurol Sci 409:116582. https://doi.org/10.1016/j.jns.2019.116582

    Article  CAS  PubMed  Google Scholar 

  8. Matos-Ribeiro J, Castro-Chaves P, Oliveira-Ferreira M, Fonseca L, Pintalhao M (2022) Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile. J Neurol 269(4):2099–2112. https://doi.org/10.1007/s00415-021-10788-z

    Article  CAS  PubMed  Google Scholar 

  9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

    Article  PubMed  PubMed Central  Google Scholar 

  10. Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27(6):1785–1805. https://doi.org/10.1177/0962280216669183

    Article  PubMed  Google Scholar 

  11. Wells G, Shea B, O’Connell D, Peterson j, Welch V, Losos M, Tugwell P (2000) The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis.

  12. Kim SR, Kim K, Lee SA, Kwon SO, Lee JK, Keum N, Park SM (2019) Effect of Red, processed, and White Meat Consumption on the risk of gastric Cancer: an overall and Dose–Response Meta-Analysis. Nutrients 11(4). https://doi.org/10.3390/nu11040826

  13. Mcpheeters ML, Kripalani S, Peterson NB, Idowu RT, Jerome RN, Potter SA, Andrews JC (2012) Cochrane Risk of Bias Tool. Cochrane Risk of Bias Tool

  14. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186

    Article  PubMed  Google Scholar 

  15. De Marchis GM, Seiffge DJ, Schaedelin S, Wilson D, Caso V, Acciarresi M, Tsivgoulis G et al (2022) Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis. J Neurol Neurosurg Psychiatry 93(2):119–125. https://doi.org/10.1136/jnnp-2021-327236

    Article  PubMed  Google Scholar 

  16. Kimura S, Toyoda K, Yoshimura S, Minematsu K, Yasaka M, Paciaroni M, Werring DJ et al (2022) Practical “1-2-3-4-Day” rule for starting direct oral Anticoagulants after ischemic stroke with Atrial Fibrillation: Combined Hospital-Based Cohort Study. Stroke 53(5):1540–1549. https://doi.org/10.1161/strokeaha.121.036695

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kimura T, Tucker A, Nakagaki A, Sugimura T, Fukuda S, Katsuno M, Fujita T et al (2021) Anticoagulation Protocol for secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation. J Stroke Cerebrovasc Dis 30(8):105893. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105893

    Article  PubMed  Google Scholar 

  18. Macha K, Volbers B, Bobinger T, Kurka N, Breuer L, Huttner HB, Schwab S et al (2016) Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke. J Stroke Cerebrovasc Dis 25(9):2317–2321. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.06.031

    Article  PubMed  Google Scholar 

  19. Oldgren J, Åsberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B (2022) Early Versus delayed Non-Vitamin K antagonist oral anticoagulant therapy after Acute ischemic stroke in Atrial Fibrillation (TIMING): a Registry-Based Randomized Controlled Noninferiority Study. Circulation 146(14):1056–1066. https://doi.org/10.1161/circulationaha.122.060666

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Paciaroni M, Agnelli G, Giustozzi M, Tsivgoulis G, Yaghi S, Grory BM, Furie KL et al (2020) Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes. Eur Stroke J 5(4):374–383. https://doi.org/10.1177/2396987320937116

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry TA, Al-Shahi Salman R et al (2019) Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. J Neurol Neurosurg Psychiatry 90(3):320–325. https://doi.org/10.1136/jnnp-2018-318890

    Article  PubMed  Google Scholar 

  22. Yaghi S, Trivedi T, Henninger N, Giles J, Liu A, Nagy M, Kaushal A et al (2020) Anticoagulation timing in Cardioembolic Stroke and recurrent event risk. Ann Neurol 88(4):807–816. https://doi.org/10.1002/ana.25844

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kamel H, Healey JS (2017) Cardioembolic stroke. Circ Res 120(3):514–526. https://doi.org/10.1161/circresaha.116.308407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J et al (2018) 2018 guidelines for the early management of patients with Acute ischemic stroke: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 49(3):e46–e110. https://doi.org/10.1161/str.0000000000000158

    Article  PubMed  Google Scholar 

  25. Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C et al (2015) Early recurrence and cerebral bleeding in patients with Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and its timing: the RAF Study. Stroke 46(8):2175–2182. https://doi.org/10.1161/strokeaha.115.008891

    Article  CAS  PubMed  Google Scholar 

  26. Seiffge DJ, Traenka C, Polymeris A, Hert L, Peters N, Lyrer P, Engelter ST et al (2016) Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events. Neurology 87(18):1856–1862. https://doi.org/10.1212/wnl.0000000000003283

    Article  CAS  PubMed  Google Scholar 

  27. Klijn CJ, Paciaroni M, Berge E, Korompoki E, Kõrv J, Lal A, Putaala J et al (2019) Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: a european Stroke Organisation guideline. Eur Stroke J 4(3):198–223. https://doi.org/10.1177/2396987319841187

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893–2962. https://doi.org/10.1093/eurheartj/ehw210

    Article  PubMed  Google Scholar 

  29. Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, Diener HC et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22(7):1048–1055. https://doi.org/10.1111/ene.12577

    Article  CAS  PubMed  Google Scholar 

  30. Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H et al (2016) Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke 11(5):565–574. https://doi.org/10.1177/1747493016632239

    Article  PubMed  Google Scholar 

  31. Canavero I, Cavallini A, Sacchi L, Quaglini S, Arnò N, Perrone P, DeLodovici ML et al (2017) Safely addressing patients with Atrial Fibrillation to Early Anticoagulation after Acute Stroke. J Stroke Cerebrovasc Dis 26(1):7–18. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.08.022

    Article  PubMed  Google Scholar 

  32. Gioia LC, Kate M, Sivakumar L, Hussain D, Kalashyan H, Buck B, Bussiere M et al (2016) Early Rivaroxaban Use after Cardioembolic Stroke May not result in Hemorrhagic Transformation: a prospective magnetic resonance imaging study. Stroke 47(7):1917–1919. https://doi.org/10.1161/strokeaha.116.013491

    Article  CAS  PubMed  Google Scholar 

  33. Fischer U, Trelle S, Branca M, Salanti G, Paciaroni M, Ferrari C, Abend S et al (2022) Early versus late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial. Eur Stroke J 7(4):487–495. https://doi.org/10.1177/23969873221106043

    Article  PubMed  PubMed Central  Google Scholar 

  34. Best JG, Arram L, Ahmed N, Balogun M, Bennett K, Bordea E, Campos MG et al (2022) Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke 17(5):583–589. https://doi.org/10.1177/17474930211057722

    Article  PubMed  Google Scholar 

  35. King BT, Lawrence PD, Milling TJ, Warach SJ (2019) Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke 14(9):977–982. https://doi.org/10.1177/1747493019870651

    Article  PubMed  PubMed Central  Google Scholar 

  36. Palaiodimou L, Stefanou MI, Katsanos AH, Paciaroni M, Sacco S, De Marchis GM, Shoamanesh A et al (2022) Early Anticoagulation in patients with Acute Ischemic Stroke due to Atrial Fibrillation: a systematic review and Meta-analysis. J Clin Med 11(17). https://doi.org/10.3390/jcm11174981

Download references

Acknowledgements

We would like to thank the researchers and study participants for their contributions.

Funding

The authors did not receive support from any organization for the submitted work.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Mengjin Jiang; Methodology: Mengjin Jiang, Yaodong Zhang, Congyao Wang; Formal analysis and investigation: Yaodong Zhang, Congyao Wang; Writing - original draft preparation: Mengjin Jiang, Congyao Wang; Writing - review and editing: Mengjin Jiang, Yaodong Zhang. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mengjin Jiang.

Ethics declarations

Competing interests

The authors declare that they have no competing interest.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, M., Wang, C. & Zhang, Y. Comparison of early and delayed anticoagulation therapy after ischemic stroke in patients with atrial fibrillation: a systematic review and meta-analysis. J Thromb Thrombolysis 56, 603–613 (2023). https://doi.org/10.1007/s11239-023-02872-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-023-02872-0

Keywords

Navigation